The perceptions and experience of the diabetic person with an insulin pump: a review of the literature
Keywords:
infusion system, perceptions, emotions, experiences, attitude to healthAbstract
Background: diabetes mellitus is a chronic disease of the endocrine system, characterized by an increase in the concentration of glucose in the blood. For patients with diabetes, it is possible to cover the need for insulin through the use of an insulin pump, a subcutaneous implantable device, which aims to simulate the action of the Langherans islets. Therapy with an insulin pump allows patients who use it to have a greater flexibility in the long-term management of diabetes.
Objective: to investigate in the literature the perceptions and experiences of patients subjected to the use of the insulin pump.
Methods: this review was carried out using the international databases Pubmed, CINAHL and COCHRANE. The mesh terms "Insulin infusion system, attitude to health, experiences, emotions, perceptions, activities of daily living" were used combined with the Boolean operator AND. Age limits and language were set and literature was investigated from 2008 to 2018, respecting specific inclusion and exclusion criteria.
Results: 260 articles from the Pubmed database were analyzed, 26 articles from Cinhal, no articles by COCHRANE; of these 188 excluded based on the reading of the abstract and because they were duplicate articles, 7 because they did not meet the inclusion criteria. 15 articles were included in the review.
Discussion: four main themes emerged regarding the personal experience of patients with insulin pumps: perceptions deriving from the use of the insulin pump, behaviour deriving from therapy, obstacles to adequate glycemic control and discrepancy between education received and reality.
Conclusions: different moods and behaviors have been reported in people who use the insulin pump: one above all the fear of hypoglycemia. There are different expectations from patients and nurses. In addition to adequate training with respect to direct patient care, training is also required for nursing staff in emotional support and in technological development.
References
2. Groat D, Grando MA, Soni H, Thompson B, Boyle M, Bailey M , Cook CB. Self-Management Behaviours in Adults on Insulin Pump Therapy: What Are Patients Really Doing? JDST 2017;11:233–239.
3. Pickup J, Keen H. Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002;25(3):593–8.
4. Bruttomesso D, Filippi A, Scotton R, Costa S. L’uso del monitoraggio glicemico continuo e del microinfusore insulinico nella donna gravida con diabete: nuove opportunità di educazione terapeutica. Il Giornale di AMD 2011;14:7-15.
5. Reidy C, Bracher M, Foster C, Vassilev I, Rogers A. The process of incorporating insulin pumps into the everyday lives of people with Type 1 diabetes: a critical interpretive synthesis. Health Expect 2018;21:714–729.
6. Taleb N, Messier V, Ott-Braschi S, Ardilouze JL, Rabasa-Lhoret R. Perceptions and experiences of adult patients with type 1 diabetes using continuous subcutaneous insulin infusion therapy: Results of an online survey. Diabetes res clin pract 2018; 144:42–50.
7. Kannan S, Satra A, Calogeras E, Lock P, Lansang MC. Insulin Pump Patient Characteristics and Glucose Control in the Hospitalized Setting. JDST 2014;8: 473–478.
8. Chamberlain JJ, Gilgen E. Do Perceptions of Insulin Pump Usability Impact Attitudes Toward Insulin Pump Therapy? A Pilot Study of Individuals With Type 1 and Insulin-Treated Type 2 Diabetes. JDST 2015;9:105–110.
9. Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. Open Med 2009;3(3):123-130.
10. Saarinen T, Fernström L, Brorsson A-L, Olinder AL. Insulin pump therapy is perceived as liberating, but to many it can imply a sense of the diabetes made visible. Euro Diabetes Nurs 2014;11:38-42.
11. Garmo A, Hörnsten Å, Leksell J. ‘The pump was a saviour for me’. Patients’ experiences of insulin pump therapy. Diabet Med 2013;30:717-723.
12. Joubert M, Morera J, Rod AVA, Parienti JJ, Reznik Y. Cross-sectional Survey and Retrospective Analysis of a Large Cohort of Adults With Type 1 Diabetes With Long-Term Continuous Subcutaneous Insulin Infusion Treatment. JDST 2014;8:1005–1010.
13. Polonsky WH, Hessler D, Layne JE, Zisser H. Impact of the Omnipod Insulin Management System on Quality of Life: A Survey of Current Users. Diabetes technol ther 2016;18:10.
14. Hayes M, Frearson S, Keller C, Cartmale A, Lewis-Hayes S. A hermeneutic phenomenological study of why adults with type 1 diabetes choose to discontinue CSII. Euro Diabetes Nurs 2011;8:12-16.
15. Alsaleh FM, Smith FJ, Taylor KM. Experiences of children/young people and their parents, using insulin pump therapy for the man- agement of type 1 diabetes: qualitative review. J Clin Pharm Ther 2012;37:140-147.
16. Hood DG, Duke G. The nature and meaning of insulin pump use in emerging adults with type 1 diabetes. Diabetes Spectr 2015;28:75-81.
17. Everett J, Bowes A, Kerr D. Barriers to improving glycaemic control in CSII. J Diabetes Nurs 2010;14:176-181.
18. Rankin D, Harden J, Noyes K, Waugh N, Barnard K, Lawton J. Parents’ experiences of managing their child’s diabetes using an insulin pump: a qualitative study. Diabet Med 2015;32:627-634.
19. Barnard KD, Wysocki T, Thabit H, et al. Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with Type 1 diabetes in the home setting. Diabet Med. 2015;32(5):601-8.
20. Todres L, Keen S, Kerr D. Continuous subcutaneous insulin infusion in Type 1 diabetes: patient experiences of ‘living with a machine’. Diabet Med 2010;27:1201-1204.
21. O’Kane A, Rogers Y, Blandford A. Concealing or revealing mobile medical devices? Designing for onstage and offstage presentation. Proceedings of the 2015 Conference on Human Factors in Computing Systems (CHI-2015) 2015;18-23.
22. Hood DG, Duke G. The nature and meaning of insulin pump use in emerging adults with type 1 diabetes. Diabetes Spectr 2015;28:75-81.
23. Tullman AJ. A Phenomenological Study of the Psychosocial Effects of Insulin Pump Therapy on the Body Image and Self-esteem of Female, Adolescent, Insulin Dependent Diabetics. Chicago, IL: The Chicago School of Professional Psychology 2013.
24. Forsner M, Berggren J, Masaba J, Ekbladh A, Olinder AL. Parents’ experiences of caring for a child younger than two years of age treated with continuous subcutaneous insulin infusion. Euro Diabetes Nurs 2014;11:7-12.
25. Jenkins EJE, Knott J, Brooks A. Insulin pump users require recurrent education for the management of pump failure. J Diabetes Nurs 2016;20:364–9.
26. Martyn-Nemeth P, Quinn L, Penckofer S, Park C, Hoferc V, Burke L. Fear of Hypoglycaemia: Influence on Glycaemic Variability and Self-Management Behaviour in Young Adults with Type 1 Diabetes. J Diabetes Complicat 2017;3:735–741.
27. Indelicato L, Mariano V, Galasso S, Boscari F, Cipponeri E, Negri C, et al., Bruttomesso D. Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy. Diabet Med 2017; 34:691–697.
28. American Diabetes Association. Standards of medical care in diabetes: 2016. Diabetes Care 2016;39(1):1-120.
Downloads
Published
Issue
Section
License
Copyright (c) 2021 Veronica Strini, Roberta Schiavolin, Ilaria de Barbieri, Angela Prendin
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Transfer of Copyright and Permission to Reproduce Parts of Published Papers.
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.
How to Cite
